Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study

BACKGROUND: The prevalence of salvage surgeries after drug therapy for non-small cell lung cancer (NSCLC) has risen, mainly due to recent progress in molecular-targeted drugs and immune checkpoint inhibitors for NSCLC. While the safety and effectiveness of salvage surgery after drug therapy for NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Shigeki, Asakura, Keisuke, Okui, Masayuki, Izawa, Naoko, Sawafuji, Makoto, Sakamaki, Hiroyuki, Shigenobu, Takao, Tajima, Atsushi, Oka, Naoyuki, Masai, Kyohei, Kaseda, Kaoru, Hishida, Tomoyuki, Yasuda, Hiroyuki, Fukunaga, Koichi, Asamura, Hisao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503184/
https://www.ncbi.nlm.nih.gov/pubmed/37715273
http://dx.doi.org/10.1186/s12957-023-03177-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503184/
https://www.ncbi.nlm.nih.gov/pubmed/37715273
http://dx.doi.org/10.1186/s12957-023-03177-5

Ejemplares similares